SDHAF2
Basic information
Region (hg38): 11:61430042-61446839
Previous symbols: [ "PGL2", "C11orf79" ]
Links
Phenotypes
GenCC
Source:
- pheochromocytoma/paraganglioma syndrome 2 (Strong), mode of inheritance: AD
- hereditary pheochromocytoma-paraganglioma (Supportive), mode of inheritance: AD
- pheochromocytoma/paraganglioma syndrome 2 (Moderate), mode of inheritance: AD
- pheochromocytoma/paraganglioma syndrome 2 (Definitive), mode of inheritance: AD
- hereditary pheochromocytoma-paraganglioma (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Pheochromocytoma/paraganglioma syndrome 2 | AD | Oncologic | The condition involves increased risk of certain types of neoplasms, and surveillance/early treatment of tumors (eg, surgical resection) may be beneficial | Oncologic | 6286462; 19628817; 20071235; 21348866; 20301715; 21224366; 22584701; 23061808; 23078982 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hereditary_pheochromocytoma-paraganglioma (487 variants)
- Hereditary_cancer-predisposing_syndrome (393 variants)
- not_provided (85 variants)
- Pheochromocytoma/paraganglioma_syndrome_2 (59 variants)
- not_specified (17 variants)
- SDHAF2-related_disorder (11 variants)
- Ovarian_cancer (3 variants)
- Pheochromocytoma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SDHAF2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017841.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 123 | 128 | ||||
| missense | 311 | 17 | 332 | |||
| nonsense | 13 | 21 | ||||
| start loss | 4 | 4 | ||||
| frameshift | 15 | 13 | 37 | |||
| splice donor/acceptor (+/-2bp) | 12 | 18 | ||||
| Total | 16 | 43 | 341 | 140 | 0 |
Highest pathogenic variant AF is 0.0000287306
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SDHAF2 | protein_coding | protein_coding | ENST00000301761 | 4 | 17488 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00000283 | 0.185 | 125728 | 0 | 20 | 125748 | 0.0000795 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.139 | 92 | 88.3 | 1.04 | 0.00000485 | 1092 |
| Missense in Polyphen | 32 | 30.644 | 1.0443 | 412 | ||
| Synonymous | -0.747 | 37 | 31.7 | 1.17 | 0.00000153 | 309 |
| Loss of Function | -0.284 | 8 | 7.18 | 1.11 | 3.09e-7 | 92 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000123 | 0.000123 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000141 | 0.000141 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000653 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays an essential role in the assembly of succinate dehydrogenase (SDH), an enzyme complex (also referred to as respiratory complex II) that is a component of both the tricarboxylic acid (TCA) cycle and the mitochondrial electron transport chain, and which couples the oxidation of succinate to fumarate with the reduction of ubiquinone (coenzyme Q) to ubiquinol. Required for flavinylation (covalent attachment of FAD) of the flavoprotein subunit SDHA of the SDH catalytic dimer. {ECO:0000255|HAMAP-Rule:MF_03057, ECO:0000269|PubMed:19628817}.;
- Disease
- DISEASE: Paragangliomas 2 (PGL2) [MIM:601650]: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. Paragangliomas can develop at various body sites, including the head, neck, thorax and abdomen. Most commonly, they are located in the head and neck region, specifically at the carotid bifurcation, the jugular foramen, the vagal nerve, and in the middle ear. {ECO:0000269|PubMed:19628817}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- rvis_EVS
- 0.01
- rvis_percentile_EVS
- 54.95
Haploinsufficiency Scores
- pHI
- 0.125
- hipred
- Y
- hipred_score
- 0.625
- ghis
- 0.468
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.781
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Low | Low |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sdhaf2
- Phenotype
Gene ontology
- Biological process
- tricarboxylic acid cycle;mitochondrial electron transport, succinate to ubiquinone;protein dephosphorylation;negative regulation of epithelial to mesenchymal transition;protein-FAD linkage;mitochondrial respiratory chain complex II assembly;negative regulation of canonical Wnt signaling pathway
- Cellular component
- nucleolus;mitochondrion;mitochondrial matrix;cytosol
- Molecular function
- protein binding